These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28286991)

  • 1. Cardiovascular disease in women, is it different to men? The role of sex hormones.
    Rosano GM; Spoletini I; Vitale C
    Climacteric; 2017 Apr; 20(2):125-128. PubMed ID: 28286991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens and cardiovascular disease: gender-related differences.
    Spoletini I; Caprio M; Vitale C; Rosano GM
    Menopause Int; 2013 Jun; 19(2):82-6. PubMed ID: 23761317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and cardiovascular disease in postmenopausal women: a systematic review.
    Spoletini I; Vitale C; Pelliccia F; Fossati C; Rosano GM
    Climacteric; 2014 Dec; 17(6):625-34. PubMed ID: 24559253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the lipid profile in post menopausal women who use estradiol and testosterone implants.
    Britto R; Araújo L; Barbosa I; Silva L
    Gynecol Endocrinol; 2012 Oct; 28(10):767-9. PubMed ID: 22397585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and longevity.
    Comhaire F
    Andrologia; 2016 Feb; 48(1):65-8. PubMed ID: 25892327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and cardiovascular disease.
    Liu PY; Death AK; Handelsman DJ
    Endocr Rev; 2003 Jun; 24(3):313-40. PubMed ID: 12788802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies.
    Sherwin BB
    Int J Fertil Womens Med; 1998; 43(2):98-103. PubMed ID: 9609209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of dementia with sex hormones: a focus on testosterone and cognition in women.
    Hogervorst E
    Minerva Med; 2012 Oct; 103(5):353-9. PubMed ID: 23042370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cardiac hypertrophy by estrogens.
    Pelzer T; Shamim A; Wölfges S; Schumann M; Neyses L
    Adv Exp Med Biol; 1997; 432():83-9. PubMed ID: 9433514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intracrinology and dehydroepiandrosterone--a new perspective for the use of androgens in hormone replacement therapy in postmenopausal women].
    Perzyło K; Kulik-Rechberger B; Gałczyński K; Rechberger T
    Ginekol Pol; 2011 Sep; 82(9):690-5. PubMed ID: 22379930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questioning the cardioprotective action of hormone replacement therapy in postmenopausal women.
    Mascitelli L; Goldstein MR; Pezzetta F
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):657-8. PubMed ID: 19424079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of cardiovascular disease with hormone replacement therapy.
    Schierbeck L
    Climacteric; 2015; 18(4):492-7. PubMed ID: 25830825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous androgens in postmenopausal women.
    Sands R; Studd J
    Am J Med; 1995 Jan; 98(1A):76S-79S. PubMed ID: 7825643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
    Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
    Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.